Salmeterol

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3030 publications

Single-slice Functional Lung MRI During Metronome-Paced Tachypnea Detects Changes in Regional Ventilation Dynamics After a Single Dose of Dual Bronchodilator Treatment in COPD.

Single-slice Functional Lung MRI During Metronome-Paced Tachypnea Detects Changes in Regional Ventilation Dynamics After a Single Dose of Dual Bronchodilator Treatment in COPD.

Journal: COPD

Published: August 12, 2026

β2-agonist toxicity in pregnancy causing troponin elevation and fetal distress.

β2-agonist toxicity in pregnancy causing troponin elevation and fetal distress.

Journal: BMJ case reports

Published: July 20, 2026

Endothelial Responses to ICS/LABA Combinations Are Determined Primarily by the Corticosteroid Component.

Endothelial Responses to ICS/LABA Combinations Are Determined Primarily by the Corticosteroid Component.

Journal: International journal of molecular sciences

Published: July 17, 2026

Inhaled Corticosteroids Influence Pulmonary Microbiota in Severe Equine Asthma.

Inhaled Corticosteroids Influence Pulmonary Microbiota in Severe Equine Asthma.

Journal: Animals : an open access journal from MDPI

Published: May 07, 2026

Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer.

Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer.

Journal: International journal of molecular sciences

Published: April 26, 2026

Design and optimization of 5-hydroxy-4H-benzo[1,4]oxazin-3-one-derived β2-adrenoceptor agonists with potent anti-asthmatic activity.

Design and optimization of 5-hydroxy-4H-benzo[1,4]oxazin-3-one-derived β2-adrenoceptor agonists with potent anti-asthmatic activity.

Journal: European journal of medicinal chemistry

Published: April 07, 2026

Combining β2-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease.

Combining β2-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease.

Journal: RSC medicinal chemistry

Published: March 30, 2026

FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.

FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.

Journal: bioRxiv : the preprint server for biology

Published: March 23, 2026

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Journal: JAMA network open

Published: March 09, 2026

In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy.

In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: February 09, 2026

Assessment of the efficacy and medication adherence of fluticasone propionate-salmeterol combination delivered via a capsule-based dry powder inhaler in asthmatic patients.

Assessment of the efficacy and medication adherence of fluticasone propionate-salmeterol combination delivered via a capsule-based dry powder inhaler in asthmatic patients.

Journal: Allergologia et immunopathologia

Published: January 20, 2026

Discovering repurposable drugs for Alzheimer's disease and related dementias: target trial emulation using decentralised real-world data.

Discovering repurposable drugs for Alzheimer's disease and related dementias: target trial emulation using decentralised real-world data.

Journal: EBioMedicine

Published: January 17, 2026

Showing 1-12 of 3,030

Last Updated: 09/19/2026